Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 13

ESCI
Impact Factor

Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889


       

Archive: Volume 13, 2023

Review

Polycythemia Vera: Barriers to and Strategies for Optimal Management

Duminuco A, Harrington P, Harrison C, Curto-Garcia N

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:77-90

Published Date: 21 December 2023

Review

Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review

Alsuhebany N, Pan C, Holovac E, Do B, McBride A

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:67-76

Published Date: 24 November 2023

Case Series

90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases

Wang J, Baidoun F, Tun HW, Alhaj Moustafa M

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:59-65

Published Date: 3 October 2023

Review

Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article

Hussain M, Yellapragada S, Al Hadidi S

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:33-57

Published Date: 15 September 2023

Case report

Successful Anatomy Adapted Therapeutic Management and Genetic Profiling of Primary Pituitary Diffuse Large B-Cell Lymphoma

Kimbrough EO, Gupta V, Jiang L, Tun HW

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:25-32

Published Date: 28 July 2023

Review

Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma

Gessese T, Asrie F, Mulatie Z

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:13-24

Published Date: 29 May 2023

Review

PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise

Bou Zeid N, Yazbeck V

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:1-12

Published Date: 8 March 2023